Chief Investigators

 

 

Professor David Goldstein – Director

TCRN role: Professor David Goldstein is the Director of the Translational Cancer Research Network (TCRN) at UNSW. In this role he brings together expertise across cancer research and clinical practice domains, delivering infrastructure and research enablers to support the clinical, educational and research endeavours of TCRN members and partners.

Professional and research interests: Professor Goldstein is a conjoint clinical professor at the Prince of Wales Clinical School, UNSW and a senior staff specialist in the Department of Medical Oncology at Prince of Wales Hospital. His research is focused on novel therapeutics trials and clinical research into pancreatic cancer, gastrointestinal stromal tumours and renal cell carcinoma; and on the psychosocial aspects of cancer care.

Career achievements: Professor Goldstein has received more than $19 million in peer-reviewed funding as a chief investigator since 2010 and $10 million as CIA, and has produced 235 peer-reviewed publications with 6657 Scopus citations. He was the treasurer of the AGITG until 2016 and was on the first executive board of COSA from 2013-2015, and was a founding member of the NSW Pancreatic Cancer Network. He is also the recipient of the Gold Maryalyan Award for services to COSA and the Vietnam Peoples Health Medal for contributions to improving cancer services to in Hue, Vietnam. 

 

 

 

Scientia Professor Mark Harris - Deputy Director

TCRN role: Scientia Professor Mark Harris is the Deputy Director of the TCRN. He leads the Continuum of Care flagship, providing leadership in primary health care, prevention and health services research within the TCRN, and translating TCRN priority and flagship research into the broader community. 

Professional and research interests: Professor Harris is the Executive Director of the Centre for Primary Health Care and Equity at UNSW. His research spans two key areas: the prevention and management of chronic diseases (diabetes, cardiovascular disease) in primary care; and health inequalities, including interventions to improve the health status of disadvantaged groups (the unemployed, refugees, asylum seekers and Aboriginal people). 

Career achievements: Professor Harris is internationally acclaimed for his public health and primary care research. He became a Fellow of the Australian Academy of Health and Medical Science in 2015, was appointed Scientia Professor at UNSW from 2013-2018, was an NHMRC Senior Professorial Research Fellow from 2011-2015 and became an Honorary Life Fellow of the RACGP in 2009. He was won numerous awards for his work, including the 2013 Muru Marri Indigenous Health Impact Prize, the 2013 Peter Baume Public Health Impact Award, a 2010 Humanitarian Award (Health category) and the 2010 Charles Bridges-Webb Medal from the Australian Association for Academic Primary Care.

 

Professor John Pimanda

TCRN role: Professor John Pimanda is the Translational Lead of the TCRN, enhancing collaborations between basic scientists and clinical practitioners within the TCRN membership. 

Professional and research interests: Prof Pimanda is a clinician scientist and head of the Stem Cell Group and the Adult Cancer Program at UNSW’s Lowy Cancer Research Centre. His research is focused on the molecular hierarchy governing stem cell development and maintenance, with a view to better understanding haematological and solid organ cancers in order to develop successful treatment strategies. 

Career achievements: Prof Pimanda is a Fellow of the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia. He completed his PhD at UNSW in 2004 as a NHMRC postgraduate scholar and undertook post-doctoral research at the University of Cambridge as a NHMRC CJ Martin/RG Menzies postdoctoral research fellow between 2004-2008. He has been funded principally by the NHMRC since establishing his research laboratory at the Lowy in 2008. He has received career development awards from the Leukemia Foundation, Ramaciotti Foundation and the Sylvia and Charles Viertel Foundation and other awards include the 2013/2014 CINSW Big Data Big Impact Award and the 2013 Early Stage Innovations Award from New South Innovations.

 

Associate Professor Winston Liauw

TCRN role: Associate Professor Winston Liauw leads the Multidisciplinary Care Groups program of the Clinical Improvements Into Care flagship. He has ongoing responsibility for implementation of the HSA Biobank at St George hospital. 

Professional and research interests: A/Prof Liauw is a conjoint associate professor at UNSW, the Director of Cancer Services for the South Eastern Sydney Local Health District and the principal oncologist in the internationally recognised Peritoneal Surface Malignancy Program at St George Hospital. His professional interests lie in gastrointestinal cancer and research ethics. 

Career achievements: Associate Professor Liauw has a Master of Medical Science in Pharmaceutical Development from UNSW and a bachelor’s degee in medicine from the University of Sydney. He has specialist qualifications in both medical oncology and pharmacology. A/Prof Liauw is a founding member and deputy chair of the New South Wales Shared Scientific Assessment Scheme, and a former chair of the Cancer Institute NSW Human Research Ethics Committee. He is a member of the Improving Palliative Care through Clinical Trials NSW, the Palliative Care Clinical Studies Collaborative and the St George and Sutherland Medical Research Foundation scientific communities. He has received more than $2 million in research funding over the course of his career.

 

Professor Phil Crowe

TCRN role: Professor Phil Crowe leads the Surgical Quality Improvements component of the Clinical Improvements into Care flagship.

Professional and research interests: Professor Crowe is the Chairman of the Department of Surgery at Prince of Wales Hospital and the Clinical Associate Dean at the Prince of Wales Clinical School, UNSW. His major surgical and research interests are sarcoma, breast and endocrine surgery.

Career achievements: Professor Crowe is highly acclaimed as a researcher, clinician and educator. He is a former Rhodes scholar and holds a PhD in surgery from the University of Oxford, as well as a Diploma of Education from UNSW. Among his many professional appointments, he is the founder and a former director of the Sydney Sarcoma Unit, the founder and current co-director of the Sarcoma and Nano-Oncology Research Group at the UNSW Lowy Cancer Research Centre, a board member of the Australian Sarcoma Study Group, and a Fellow of the Royal College of Surgeons of Canada. Professor Crowe won the UNSW Dean’s Scholarship for Excellence in Teaching in 1996 and was awarded best clinical teacher at Prince of Wales Hospital in 1994 and again in 2004. 

Professor Jane Phillips

TCRN role: Professor Jane Phillips is a senior research lead in the 2025 Cancer Workforce flagship. 

Professional and research interests: Professor Phillips is the Director of the Centre for Cardiovascular and Chronic Care at the University of Technology Sydney and an adjunct professor at the University of Notre Dame. Her research interests include palliative care, breast cancer and health care reform. 

Career achievements: Professor Phillips has led several successful complex reform projects, and multi-site clinical trials in the translational cancer space. She currently co-leads a National Breast Cancer Foundation Grant to advance person-centred care for cancer patients, and a NSW Government-funded project to investigate medicinal marijuana use for cancer-related conditions. Professor Phillips is the Chair of the PaCCSC Trials Management Committee and President of Palliative Care Nurses Australia. She is an editor of Collegian and a member of the International Journal of Palliative Nursing editorial board, and has research partnerships at Cambridge University, Hull York Medical School and Johns Hopkins University. She was the winner of the 2013 Vincent’s Clinic Foundation Clinical Excellence Award – Nursing and the inaugural recipient of the TCRN’s Cancer Challenge of the Year Award in 2012.

Professor Jeffrey Braithwaite

TCRN role: Professor Jeffrey Braithwaite has an international reputation as a health services and systems researcher; he will provide leadership in the areas of Implementation Science and T3 research.

Professional and research interests: Professor Jeffrey Braithwaite is the Founding Director of the Australian Institute of Health Innovationand Director of the Centre for Healthcare Resilience and Implementation Science at Macquarie University. His research interests are focused on health systems improvement, implementation science and patient safety. 

Career achievements: Professor Braithwaite is a visiting or adjunct Professor at Newcastle University, and University of Birmingham in the UK; University of Southern Denmark; University of New South Wales; and Honorary Senior International Research Fellow at the Canon Institute for Global Studies in Tokyo, Japan. He has over 600 publications to his name, including 400 refereed contributions, in journals such as the British Medical JournalThe Lancet, PLoS Medicine, and the International Journal for Quality in Health Care. He has presented and chaired at international and national events on more than 780 occasions, including over 75 keynote addresses, and has received nearly $60 million in research funding over the course of his career. He is a referee for 30 journals and health research bodies of Ireland, New Zealand, Switzerland and the United Kingdom.